STUM: Potential Drug Target and Biomarker for Many Diseases (G375057)

Target Name: STUM

NCBI ID: G375057

STUM

STUM: Potential Drug Target and Biomarker for Many Diseases

STUM, or mechanosensory transduction mediator homolog, is a protein that plays a crucial role in the sense of touch. It is a member of the STOM complex, which is a family of proteins that help regulate the mechanical sense of touch. STUM is unique because it is a potent modulator of the protein RhoA, which is involved in many cellular processes. This protein has been shown to be involved in a wide range of physiological processes, including the regulation of pain, inflammation, and cell survival. As a result, STUM has been identified as a potential drug target and a biomarker for a variety of diseases.

The mechanical sense of touch is the ability to sense the position, texture, and temperature of the body's surface. This sense is mediated by the sense of touch protein, which is a transmembrane protein that is involved in the transmission of Mechanical information Information) from the skin to the central nervous system. STUM is one of the key proteins involved in this process.

STUM is a 21-kDa protein that is expressed in many different tissues and cells. It is highly conserved, with a calculated pI of 7.9. This makes it a good candidate for a drug target. The protein is involved in the regulation of many cellular processes, including the development and maintenance of tissues and organs, as well as the regulation of pain and inflammation.

One of the ways that STUM is involved in these processes is through its role in the regulation of cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. STUM is involved in the regulation of cell adhesion by promoting the formation of tight junctions, which are a type of adhesion that is essential for the development of tissues and organs.

STUM is also involved in the regulation of pain and inflammation. Pain is a complex biological sensation that is mediated by the transmission of Chemical Information from the body's tissues to the central nervous system. The development of pain is often associated with the release of inflammatory mediators, such as prostaglandins. STUM is involved in the regulation of the release of these mediators by activating the protein TrkA, which is involved in the regulation of pain perception.

In addition to its role in pain and inflammation, STUM is also involved in the regulation of cell survival. Prolonged exposure to mechanical stress can lead to the release of pro-inflammatory mediators, which can cause damage to tissues and organs. the regulation of cell survival by activating the protein p53, which is involved in the regulation of DNA damage and cell apoptosis.

STUM has been shown to be involved in a wide range of diseases and conditions, including cancer, pain, and neurodegenerative diseases. As a result, it has been identified as a potential drug target and a biomarker for a variety of diseases. For example, studies have shown that inhibiting the activity of STUM can reduce the formation of cancer cells, and that this effect is dependent on the activity of TrkA, which is a key mediator of pain perception. In addition, STUM has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and has been shown to be involved in the regulation of neurodegenerate drug sensitivity.

In conclusion, STUM is a protein that plays a crucial role in the sense of touch and is involved in the regulation of many cellular processes. Its unique structure and function make it a potential drug target and a biomarker for a variety of diseases. Further research is needed to fully understand the role of STUM in these processes and to develop effective treatments for the prevention and treatment of these diseases.

Protein Name: Stum, Mechanosensory Transduction Mediator Homolog

The "STUM Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STUM comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets